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ABSTRACT Bruton's tyrosine kinase (Btk) is a recently
described B-cell-specific tyrosine kinase. Mutations in this gene
lead to human X chromosome-linked agammaglobulinemia
and murine X-linked inmunodeficiency. Although genetic
evidence strongly suggests that Btk plays a crucial role in
B-lymphocyte differentiation and activation, its precise mech-
anism of action remains unknown, primarily because the
proteins that it interacts with have not yet been identified.
Here, we show that Btk interacts with Src homology 3 domains
of Fyn, Lyn, and Hck, protein-tyrosine kinases that get acti-
vated upon stimulation of B- and T-cell receptors. These
interactions are mediated by two 10-aa motifs in Btk. An
analogous site with the same specificity is also present in Itk, the
T-cell-specific homologue of Btk. Our data extend the range of
interactions mediated by Src homology 3 domains and provide
an indication of a link between Btk and established signaling
pathways in B lymphocytes.
Tyrosine phosphorylation is one of the earliest events during
B-lymphocyte activation. When the B-cell receptors on the
surface of resting splenic B cells or certain B-cell lines are
cross-linked by anti-immunoglobin antibody, within 10 min
more than a dozen proteins become phosphorylated on
tyrosine (1). Among these are certain Src family tyrosine
kinases such as Fyn, Lyn, and Hck, which are associated
with the B-cell receptor complex in resting B cells (2-4). How
clustering of the B-cell receptor complex might lead to
activation of protein-tyrosine kinases remains to be shown.
Recently, a kinase called Bruton's tyrosine kinase (Btk) has
been discovered, which seems to play a central role in B-cell
signaling events. Mutations of this gene are responsible for
X-linked agammaglobulinemia, a severe human immunode-
ficiency disease, and murine X-linked immunodeficiency
(5-8). It belongs to a subgroup of Src-related kinases includ-
ing Itk found in T cells and Tec II found in liver and myeloid
cells (9, 10). Like all other members of the Src family, Btk
contains a tyrosine kinase domain, a Src homology (SH) 2
domain, and an SH3 domain. The long amino-terminal region
in Btk is similar to those in Itk and Tec II but is not shared
by other Src kinases and contains an apparent pleckstrin
homology (PH) domain (11). To understand how Btk is
involved in B-cell development and activation, we have
searched for proteins with which Btk might interact. We
show that Btk has a specific binding site that interacts with
the SH3 domains of the Src-related Fyn, Lyn, and Hck
kinases. These interactions occur through two proline-
containing 10-aa sites in the amino-terminal region of Btk,
just carboxyl-terminal to the PH domain. We suggest that Btk
is on the pathway of signaling by which fyn, lyn, and hck
control cellular events.
MATERIALS AND METHODS
Cloning. To isolate Btk cDNA clones, oligonucleotides
corresponding to either the amino terminus or carboxyl
terminus of the human Btk protein were made according to
the published sequences (5) and used to probe duplicate lifts
of A phage plaques on filters. Ten independent doubly pos-
itive clones were isolated from -1 x 106 phage plaques. We
partially sequenced these 10 cDNA clones and found that
they all contained the full-length Btk coding sequence. A
DNA fragment containing the amino-terminal portion of a
mouse Btk cDNA clone was constructed in the EG202
vector, which contains the LexA DNA binding domain as its
amino terminus (12). When this LexA-BtkN bait, along with
the reporter plasmid pSH18-34 containing the LexA binding
site driving the lacZ gene, was transformed into the yeast
strain EGY48 (MATa, trpl, ura3, his, Leu2.plexAop6-leu2),
colonies required leucine to grow and did not turn blue on
5-bromo-4-chloro-3-indolyl -D-galactoside (X-Gal) medium.
Thus, the bait did not contain intrinsic transactivation po-
tential and was suitable for library screening. Library plas-
mids (pJG4-5) containing the B42 acidic activation domain
and cDNAs derived from HeLa cells were then transformed
into the yeast clone carrying both the LexA-BtkN bait and
the reporter plasmid pSH18-34. A total of 4.5 x 106 yeast
transformants were selected on Ura-, His-, Trp-, and Leu-
X-Gal/galactose plates. Approximately 3000 colonies grew in
the absence of leucine, but only 90 turned blue. Because the
library vector pJG4-5 used here contained a galactose-
inducible promotor, colonies of authentic interacting clones
should turn blue when galactose but not glucose is used as a
carbon source. Colony replicas of the 90 clones were plated
onto both X-Gal/glucose and X-Gal/galactose plates, and 70
showed unambiguous galactose-dependent blue color. Plas-
mid DNAs were isolated from 12 of these clones, and library
plasmids were selected through their tryptophan synthase
gene. They were purified and reintroduced back into yeast
strain EGY48 along with the reporter plasmid pSH18-34 plus
either the pEG202-lexA-BtkN or pEG202 vector. Colonies
were replicated onto either glucose/X-Gal or galactose/X-
Gal plates. Clones with specific Btk-interacting proteins
showed blue color on galactose/X-Gal plates only with
pEG202-LexA-BtkN as bait. The insert from one clone was
sequenced and found to correspond to the amino-terminal
region of the human FYN gene.
The Source of the Various SH3 Domains. GST-Abl-SH3 and
GST-Src-SH3 have been described (13). The sequences cod-
ing for the SH3 domains of mouse Btk (amino acid residues
218-276), bovine Blk (55-113), and chicken Fyn (80-144)
were amplified from the corresponding cDNAs, whereas
those of mouse Lyn (64-124) and mouse Hck (60-116) were
amplified by reverse transcriptase-PCR using polyadenylyl-
ated mRNAs isolated from BALB/c mouse spleen. These
various DNA fragments were ligated in-frame to the pGex2T
Abbreviations: Btk, Bruton's tyrosine kinase; SH, Src homology;
GST, glutathione S-transferase; IPTG, isopropyl ,-D-thiogalacto-
side; PH, pleckstrin homology.
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vector and were sequenced using a primer derived from the
vector. Glutathione S-transferase (GST)-SH3 fusion proteins
were purified from isopropyl 3-D-thiogalactoside (IPTG)-
induced bacterial lysates and were subsequently biotinylated
as described (13, 14).
Solution Binding Assays. One liter of IPTG-induced bacte-
ria expressing either GST or GST-Hck-SH3 was lysed in 10
ml of ice-cold lysis buffer (PBS/100 mM EDTA/1% Triton
X-100/1% aprotinin/1 mM phenylmethylsulfonyl fluoride)
by sonication. The supernatants were incubated with 250 ,Ld
of glutathione-agarose for 30 min at 40C. These GST- or
GST-Hck-SH3-saturated agarose beads were then washed
four times with the lysis buffer and stored in an equal volume
of PBS. To produce and detect Btk, we used a mammalian
expression construct, pGD-BTK-FLU, made by ligating the
full-length coding region of Btk cDNA in-frame to the 5' end
of the influenza hemagglutinin tag (FLU) in the retrovirus
vector pGD-FLU. To create Btk(4A) mutations, PCR muta-
genesis was performed (15). Approximately 2 x 107 293 cells
either untransfected or transiently transfected with pGD-
BTK-FLU or pGD-BTK(4A)-FLU were lysed in 1 ml of the
lysis buffer (1% Nonidet P-40/150 mM NaCl/20 mM Hepes,
pH 7.5/10 mM NaF/0.4 mM EDTA/50 mM Na3VO4/1 mM
phenylmethylsulfonyl fluoride/1 mM leupeptin/1% aproti-
nin) on ice for 30 min. The supernatants were incubated with
5 ,u1 of the glutathione-agarose beads containing either GST
or GST-Hck-SH3 for 2 hr in a cold room with rotation. The
precipitated complexes were then washed four times with the
lysis buffer before Western blot assays with anti-FLU anti-
body.
RESULTS
To isolate cDNAs encoding proteins that interact with Btk,
we used the yeast two-hybrid trapping method (12, 16).
Full-length mouse Btk cDNA clones were isolated by screen-
ing a AgtlO library made from the mouse pre-B cell line 22D6
with oligonucleotide probes synthesized according to the
published sequences (5). To identify proteins that specifically
interact with Btk, we used the amino-terminal portion of Btk
as bait because this region is conserved among the Itk and
Tec subfamily but is distinct from sequences in other Src
family members. It contains a PH domain (11). We adopted
the yeast two-hybrid system developed in Brent's laboratory
(12). The bait was linked to the LexA DNA binding domain
and interacted in yeast cells with a galactose-controlled,
activation domain-linked HeLa cell cDNA library. The re-
porters were /3-galactosidase and Leu2 directed by LexA
binding sites. One of the interacting clones we isolated, when
sequenced, was found to represent the amino-terminal region
of the human FYN gene; it contained the SH3 domain and a
portion of the SH2 domain.
To test whether Fyn can interact directly with Btk, in vitro
filter binding assays were performed. The cDNA fragment
from the isolated clone was transferred into the vector
pGex-lZT, which can express in bacteria GST fusion pro-
teins in the same frame as the LexA fusion proteins of yeast.
The GST fusion protein containing the amino-terminal por-
tion of human Fyn (GST-Fyn-N) was purified and biotiny-
lated as described (13, 14). Total IPTG-induced bacterial cell
lysates expressing the GST fusion protein containing the
full-length Btk (GST-Btk-F) were fractionated by SDS/
PAGE, transferred to nitrocellulose, and probed with biotin-
ylated GST-Fyn-N fusion peptides. The GST-Fyn-N probe
specifically recognized the GST-Btk-F protein but not the
GST alone (Fig. 1), showing that the amino-terminal portion
of Fyn interacts directly with Btk.
When GST-Fyn-N was used to probe fragments of Btk, the
amino-terminal fragment, Btk-N, was recognized but Btk-H,
which lacked only 44 carboxyl-terminal amino acids of
Btk-N, did not bind (Fig. 1). A fragment of Itk similar to
Btk-N was also tested and was bound by the GST-Fyn-N
probe as strongly as was the Btk fragment (9). These results
indicate that Btk can interact with Fyn through a relatively
small region located immediately amino-terminal to the Btk
SH3 domain. The association of Fyn with both Btk and Itk
suggests that the two tyrosine kinases may be involved in
similar pathways during B- or T-cell development and acti-
vation.
The regions of Btk and Itk that contained the binding sites
have a common 10-aa sequence, KKPLPPTPEE/D (Fig.
2A). (KKPLPPTPEE is designated BB3-1, the first Btk
binding site for SH3). In the same region there is another
similar sequence KKPLPPEPTA (BB3-2) present in Btk but
not in Itk. Both sequences are rich in proline residues and, as
shown previously, proline-rich sequences can mediate pro-
tein-protein interactions involving certain SH3 domains (14).
Because the clone isolated by the yeast two-hybrid trap-
ping method contained a complete Fyn SH3 domain, it
seemed likely that Fyn interacted with Btk through the
binding of its SH3 domain to these two proline-rich se-
quences. To test this possibility, we introduced a DNA
fragment containing just the SH3 domain of the chicken Fyn
gene into the pGex2T vector. The GST fusion protein,
GST-Fyn-SH3, was purified from IPTG-induced bacteria and
biotinylated. It was used to probe filters containing total
bacterial lysates expressing equal amounts of either GST,
GST-BB3-1, or GST-BB3-2. The GST-Fyn SH3 probe rec-
ognized both GST-BB3-1 and GST-BB3-2 but not GST alone
(Fig. 2B). In a similar way, we examined the binding spec-
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FIG. 1. Mapping of the Fyn binding site on Btk. Various DNA fragments from Btk and Itk were fused in-frame to the GST gene in pGEX.
GST-BTK-F contained the full-length Btk protein (residues 1-659), whereas GST-BTK-N and GST-BTK-H contained Bik fragments of 1-218
and 1-174, respectively. GST-ITK-N contained the amino-terminal portion of the mouse Itk protein (1-181). The cDNA fragment from the Fyn
clone was transferred into the vector pGex-lZT, which can express GST fusion proteins in bacteria in the same frame as the LexA fusion proteins
of yeast. The GST fusion protein containing the amino-terminal portion of Fyn (GST-Fyn-N) was purified and biotinylated as described (12,
13). Total IPTG-induced bacterial cell lysates expressing GST fusion proteins containing various fragments of Btk or Itk were fractionated by
SDS/PAGE, transferred to nitrocellulose, and probed with biotinylated GST-Fyn-N fusion peptides. P, proline-rich region.
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FIG. 2. Determination of the specificities of the SH3 binding sites in Btk by in vitro filter binding assays. (A) Amino acid sequences of Btk
and Itk corresponding to the putative Fyn binding site. (B) Proteins from bacterial lysates expressing equal amounts of GST, GST-BB3-1, or
GST-BB3-2 were probed with biotinylated GST-Abl-SH3, GST-Blk-SH3, GST-Btk-SH3, GST-Fyn-SH3, GST-Hck-SH3, GST-Lyn-SH3,
GST-Src-SH3, GST, or anti-GST antibody (1 Ag/ml) as described (12, 13).
ificities of BB3-1 and BB3-2 to a variety ofSH3 domains. The
Btk sites were not bound by Abl-SH3, Blk-SH3, Btk's own
SH3, or Crkl SH3 (data not shown). However, they bound
to the SH3 domains of both Lyn and Hck at least as strongly
as they bound to Fyn SH3 (Fig. 2B). A weak interaction
between Src SH3 and BB3-1 or BB3-2 was revealed after
longer exposures than were required to see the other inter-
actions (we estimate it to be <10% of the strong interactions).
Src SH3 is closer in sequence to Fyn SH3 than to others,
highlighting the ability of similar SH3s to distinguish among
potential binding sites.
To examine whether the SH3 domains of Fyn, Lyn, and
Hck interact with full-length Btk in solution, we bound the
SH3 region ofHck to beads and collected proteins that bound
to the beads. To produce and detect Btk, we used a mam-
malian expression construct, pGD-BTK-FLU, made by li-
gating the full-length coding region of Btk cDNA in-frame to
the 5' end of the influenza hemagglutinin tag (FLU) in the
retrovirus vector pGD-FLU. The construct was transiently
transfected into 293 cells and, after 2 days, immunoprecipi-
tation and Western blots of total cell lysates with anti-FLU
antibody showed that Btk was present in transfected but not
in nontransfected cells (Fig. 3B, lanes 7 and 8). The lysates
were then incubated with glutathione-agarose beads coupled
either to GST-Hck-SH3 or to GST alone. Bound proteins
were solubilized and analyzed in a Western blot developed
with anti-FLU monoclonal antibody (12CA5). A single band
the size of Btk-FLU was bound by GST-Hck-SH3 but not by
GST (Fig. 3B, lanes 2 and 5). No band was detected when
untransfected 293 cell protein was analyzed (lane 4). Thus,
Hck SH3 binds to Btk in solution.
To show that the interaction of Btk with the Hck SH3
domain is through the BB3-1 and BB3-2 sites, we made a
construct, BTK(4A), containing point mutations in both sites
by converting the codons for four proline residues into those
for alanine (Fig. 3A) (15). These mutations did not interfere
with Btk's kinase activity as shown by in vitro kinase assays
(data not shown). The wild-type and mutant proteins were
made as GST fusions to the same level in bacteria (Fig. 3C,
lanes 1 and 3), but the mutations completely abolished the
binding by Hck SH3 to the filter-bound proteins (Fig. 3C,
lanes 4 and 6). In 293 cells, the mutated Btk was made (Fig.
3B, lane 9) but not bound by GST-Hck-SH3 (Fig. 3B, lane 6).
Thus, the association of the SH3 domain of Hck with
full-length Btk requires the proline residues in the BB3-1 and
BB3-2 sites of Btk.
DISCUSSION
Our studies have uncovered an affinity between three Src-
related proteins and Btk or Itk. This affinity both shows how
SH3 binding specificity can determine protein-protein asso-
ciations and suggests that the critical Btk kinase is integrated
into the signaling pathway that involves kinases closely related
to Src. From the point of view of SH3 specificity, the present
work as well as that of others shows that SH3 can mediate
highly selective interactions. Thus BB3-1 and BB3-2 are clear
examples of binding sites specific for particular SH3 domains
in that they are recognized by SH3s from Fyn, Lyn, and Hck
but not those from other Src family members such as Btk and
Blk. It has been shown that polyproline is not a good binding
site for SH3 domains so that amino acids other than proline
must be required for SH3 binding. These studies, as well as
earlier ones on the Abl SH3 binding specificity (13, 14) and
recent ones on sites in Abl that preferentially interact with Crk
and Nck SH3 domains (R. Ren, Z.-S.Y., and D.B., unpub-
lished results), show that amino acid residues around the
proline residues confer binding selectivity. In fact, BB3-1
(KKPLPPTPEE) and BB3-2 (KKPLPPEPTA) differ only in
their carboxyl-terminal three amino acids and yet display at
least a 10-fold difference in affinity for the Fyn, Lyn, and Hck
SH3s. A recently published study shows that a Pro-Xaa-Xaa-
Pro motif as well as flanking amino acids interacts with SH3
domains (17). SH3s are known to mediate protein-protein
interactions in various circumstances, including the binding of
an adapter molecule, Grb2, to SOS, a guanine-nucleotide
releasing protein (18). Interactions of dynamin with several
SH3-containing proteins such as p85a, phospholipase C--y, and
Grb2 have also been shown (19). So far, more than 30
individual proteins have been found to contain SH3 domains
(20). We expect that they represent many different specificities
of interaction. These specificities are all, thus far, for short
linear amino acid sequences and resemble in their diversity the
specificities attributed to antibodies for their epitopes.
Perhaps the most important aspect of this work is the
demonstration that Btk and Itk can interact with Fyn, Lyn,
and Hck. Btk is unique among the protein-tyrosine kinases in
B cells in that it has been proved by mutagenesis to be critical
to human B-cell development and to signaling in the mature
mouse B cells. Most B cells in X-linked agammaglobulinemia
patients are blocked at the VH-to-DJH rearrangement stage
(21). Interestingly, dominant-negative mutations of the Lck
protein-tyrosine kinase gene in transgenic mice block T-cell
development at the equivalent stage (V1rto-DJq joining) (22).
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Interestingly, Btk protein did not interact detectably with
full-length Fyn protein in 293 cells (data not shown), although
it interacted with Fyn SH3 in yeast cells and in solution.
Possibly, in the full-length Fyn protein the SH3 domain is
cryptic and unavailable for binding to Btk in the native state
and becomes exposed only after activation.
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FIG. 3. Binding of full-length Btk protein and the Hck SH3
domain in solution. (A) Schematic representation of Btk with the
amino acid sequences around the SH3 binding sites, BB3-1 and
BB3-2 (underlined). BTK(4A) is the mutant form of Btk where four
proline residues in the SH3 binding sites have been mutated to
alanine residues. (B) Solution binding assays. Cell lysates from
untransfected 293 cells (lanes 1, 4, and 7), 293 cells transfected with
pGD-Btk-Flu (lanes 2, 5, and 8), and 293 cells transfected with
pGD-Btk(4A)-Flu (lanes 3, 6, and 9) were precipitated with GST
(lanes 1-3), GST-Hck-SH3 (lanes 4-6), or anti-FLU antibody (lanes
7-9). The precipitated complexes were Western blotted and probed
with anti-FLU antibody. The arrow indicates the full-length BTK-
FLU or BTK(4A)-FLU. (C) Filter binding assays. Proteins from
bacterial lysates expressed GST-Btk (lanes 1 and 4), GST (lanes 2 and
5), and GST-Btk(4A) (lanes 3 and 6) were probed with either
anti-GST antibody (lanes 1-3) or the biotinylated GST-Hck-SH3
(lanes 4-6). The arrow indicates the intact GST-BTK or GST-
BTK(4A). Molecular size markers (in kDa) are indicated.
It is possible that Lck acts through Btk's homologue, Itk,
during T-cell development. The role of Btk in B-cell activa-
tion is unclear. It is largely located in the cytoplasm and is not
tyrosine phosphorylated in the pre-B cell line, 70Z, as well as
in resting splenic B cells, suggesting that it may require other
proteins for its activation (6-8). On the other hand, Fyn, Lyn,
and Hck have been shown to be associated with the B-cell
receptor complex in unactivated B cells and are rapidly
phosphorylated on tyrosine after cross-linking with anti-IgM
antibody (2-4). Our studies suggest that they are good
candidates for carrying out Btk activation. We have, how-
ever, been unable to convincingly demonstrate that Btk
becomes phosphorylated when WEHI 231 cells are activated
by anti-IgM antibody (G.C. and D.B., unpublished results).
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